The FDA approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for the treatment of major depressive ...

Serial adjunctive ketamine infusions are not more effective than serial midazolam infusions in reducing depressive symptoms.

The aim was to measure depression severity change from baseline to day five using the Montgomery-Åsberg Depression Rating Scale.

Another of the psychiatry drugs Neurocrine Biosciences licensed from Takeda has stumbled in the clinic. | Another of the ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 2 study evaluating the efficacy, safety and tolerability of investigational compound NBI-1070770 in adults with major ...

Caplyta, the crown jewel of Johnson & Johnson's $14.6 billion buyout of Intra-Cellular Therapies, won the FDA’s blessing to ...

Millions of Americans with anxiety and depression struggle to find the right medication. The best fit may depend on your ...

Researchers identified SGK1 as a key chemical connecting childhood trauma to depression and suicidal behavior. High SGK1 ...

The expanded indication for the oral atypical antipsychotic now includes adjunctive use with antidepressants in adults with major depressive disorder.

To provide some solid data, the authors of the new study gave LSD to a group of patients in New Zealand, and instructed them ...

Long-term breast cancer survivors have a higher risk for developing depression, particularly if they have insomnia, according ...

Learn about seasonal affective disorder (SAD) and how to manage the winter blues. Expert tips from Sarah Gagnon on vitamin D, light therapy, and more.